SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-002767
Filing Date
2019-01-22
Accepted
2019-01-22 17:17:05
Documents
3
Period of Report
2019-01-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a19-3294_18k.htm 8-K 44209
2 EX-99.1 a19-3294_1ex99d1.htm EX-99.1 9065
3 GRAPHIC g32941mmi001.jpg GRAPHIC 4317
  Complete submission text file 0001104659-19-002767.txt   60707
Mailing Address 301 NORTH MAIN STREET, SUITE 100 ANN ARBOR MI 48104
Business Address 301 NORTH MAIN STREET, SUITE 100 ANN ARBOR MI 48104 734-845-9000
Millendo Therapeutics, Inc. (Filer) CIK: 0001544227 (see all company filings)

IRS No.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35890 | Film No.: 19535978
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1